The presence of extended-spectrum β-lactamase as a risk factor for MDR in clinical isolation of Escherichia coli

被引:0
|
作者
Asgharzadeh Kangachar, Sh [1 ]
Mojtahedi, A. [2 ]
机构
[1] Guilan Univ Med Sci, Fac Paramed, Langroud, Iran
[2] Guilan Univ Med Sci, Mol & Cellular Res Ctr, Fac Med, Rasht, Iran
关键词
URINARY-TRACT-INFECTIONS; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; PATHOGENS; PREVALENCE; INTEGRONS; PATTERNS; BACTERIA; STRAINS; SUSCEPTIBILITY;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Significant increases in antibiotic resistance have become a critical dilemma in healthcare systems around the world. Enterobacteriaceae acquired different mechanisms of antibiotic resistance such as ESBLs production and transposon attainment, which hold antibiotic resistance genes. This may create multidrug resistant (MDR) strains. Antibiotic resistance patterns vary in different geographical regions. The present estimated-cross sectional study is aimed to determine antibiotic resistance pattern of 182 E. coli strains to 20 antibiotics. Three different methods were applied to detect the ESBL-producing E. coli. Observations revealed that oxacillin, amoxicillin and ampicillin had the lowest effect, while imipenem, gentamicin and nitrofurantoin had the highest impact on clinical E. coli strains in our region. Three different methods, including double disk synergy test (DDST) (30 mm), double disk synergy test (DDST) (20mm) and combined disk test were used to identify ESBL-producing E. coli. The prevalence of ESBL producers was at a 35.71% rate. Findings of this study indicate that there is no significant difference between these three methods in identifying ESBLproducing E. coli. There was a significant relation between ESBL production and resistance to three other classes of antibiotics, including protein synthesis inhibitor, Quinolones and Metabolite analogues. Moreover, antibiotic resistance rate in ESBL-producing E. coli was significantly higher than non ESBL-producing isolates. The MDR was at a 65.93% rate. Unfortunately, the rate of antibiotic resistance is globally increasing; this is due to several factors such as inappropriate antibiotic use, incomplete course of antibiotics use, protracted length of stay in hospitals and self-medication. Resistance mechanisms such as ESBL production and MDR cause treatment failure. Our findings suggest that ESBL production is a risk factor for MDR in clinical E. coli. Therefore, Physicians are recommended to stop excessive and long term administration of antibiotics.
引用
收藏
页码:98 / 109
页数:12
相关论文
共 50 条
  • [31] Factors for Occurrence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Broilers
    Hiroi, Midori
    Matsui, Shigeyuki
    Kubo, Ryoichi
    Iida, Natsuko
    Noda, Yoshihiro
    Kanda, Takashi
    Sugiyama, Kanji
    Hara-Kudo, Yukiko
    Ohashi, Norio
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2012, 74 (12): : 1635 - 1637
  • [32] Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands
    Overdevest, Ilse
    Willemsen, Ina
    Rijnsburger, Martine
    Eustace, Andrew
    Xu, Li
    Hawkey, Peter
    Heck, Max
    Savelkoul, Paul
    Vandenbroucke-Grauls, Christina
    van der Zwaluw, Kim
    Huijsdens, Xander
    Kluytmans, Jan
    EMERGING INFECTIOUS DISEASES, 2011, 17 (07) : 1216 - 1222
  • [33] Impact of antibiotic usage on extended-spectrum β-lactamase producing Escherichia coli prevalence
    Kim, Jeong Yeon
    Yum, Yunjin
    Joo, Hyung Joon
    An, Hyonggin
    Yoon, Young Kyung
    Kim, Jong Hun
    Sohn, Jang Wook
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [34] Relevance of class 1 integrons and extended-spectrum β-lactamases in drug-resistant Escherichia coli
    Liu, Li-Tao
    Wan, Li-Hong
    Song, Xiao-Hong
    Xiong, Yao
    Jin, Shao-Ju
    Zhou, Li-Ming
    MOLECULAR MEDICINE REPORTS, 2013, 8 (04) : 1251 - 1255
  • [35] Phylogenetic and antibiotics resistance in extended-spectrum B-lactamase (ESBL) Uropathogenic Escherichia coli: An update review
    Matinfar, Solmaz
    Ahmadi, Majid
    Sisakht, Adib Molaei
    Sadeghi, Javid
    Javedansirat, Saeed
    GENE REPORTS, 2021, 23
  • [36] Molecular characterization of quinolone resistance mechanisms and extended-spectrum β-lactamase production in Escherichia coli isolated from dogs
    Meireles, D.
    Leite-Martins, L.
    Bessa, L. J.
    Cunha, S.
    Fernandes, R.
    de Matos, A.
    Manaia, C. M.
    Martins da Costa, P.
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2015, 41 : 43 - 48
  • [37] Occurrence of extended-spectrum β-lactamase, AmpC and virulence genes in Escherichia coli isolates from vegetable salads in Morocco
    Nayme, Kaotar
    Barguigua, Abouddihaj
    Bouchrif, Brahim
    Diawara, Idrissa
    El Otmani, Fatima
    Elmdaghri, Naima
    Zerouali, Khalid
    Timinouni, Mohammed
    BRITISH FOOD JOURNAL, 2017, 119 (07): : 1633 - 1647
  • [38] Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco
    Barguigua, Abouddihaj
    El Otmani, Fatima
    Talmi, Mustapha
    Bourjilat, Fatna
    Haouzane, Fatima
    Zerouali, Khalid
    Timinouni, Mohammed
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (09) : 1344 - 1352
  • [39] Genetic Features of Extended-Spectrum β-Lactamase-Producing Escherichia coli from Poultry in Mayabeque Province, Cuba
    Baez, Michel
    Espinosa, Ivette
    Collaud, Alexandra
    Miranda, Iliana
    Montano, Damarys de las Nieves
    Feria, Angel L.
    Hernandez-Fillor, Rosa Elena
    Obregon, Dasiel
    Alfonso, Pastor
    Perreten, Vincent
    ANTIBIOTICS-BASEL, 2021, 10 (02): : 1 - 14
  • [40] Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
    Rodriguez-Bano, Jesus
    Picon, Encarnacion
    Gijon, Paloma
    Ramon Hernandez, Jose
    Ruiz, Maite
    Pena, Carmen
    Almela, Manuel
    Almirante, Benito
    Grill, Fabio
    Colomina, Javier
    Gimenez, Monserrat
    Oliver, Antonio
    Pablo Horcajada, Juan
    Navarro, Gemma
    Coloma, Ana
    Pascual, Alvaro
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) : 40 - 48